Issues: Vax Specific

Anthrax

Hepatitis B

Hib 

HPV

Influenza

Lyme Disease
Meningococcal

MMR    

Pneumococcal

Polio

Rotavirus

● Smallpox

Tdap/Td

Varicella

Yellow Fever

 

Issues: Misc

Exemptions

Legislation 

New Vax Status

Religion

Thimerosal

 

Vaccine Info

2014 Schedule

ACIP Recs

Components
IOM Reports

● Vax Injury Comp Program
Manufacturer Links

Package Inserts

Reporting AEs

Thimerosal Table

VAERS

VISs

 

Links
 

Search
 

About IVS

Faculty Biographies

Publications

Donations

 

Email IVS

 

Disclaimers & Privacy
 

 

Yellow Fever Vaccine

  • Yellow Fever Vaccine Information Statement updated 3/30/11 link

  • ACIP Recommendations updated 7/30/10 pdf | html

  • Maps of 2010 Endemic areas in Africa and South/Central America.

  • Persons With Diseases of the Thymus Should Consider Alternatives to Receiving Yellow Fever Vaccine CDC investigators have identified diseases of the thymus as a possible risk factor for severe complications following yellow fever vaccine. [click for more info].  Barwick R. History of thymoma and yellow fever vaccination. Lancet 2004; 364(9438):936. 

  • Evidence of rare, severe adverse reactions to 17D Yellow Fever Vaccine  Three articles and a commentary in the July 14, 2001 issue of the Lancet provide data on 7 people who developed severe yellow-fever like illness following yellow fever vaccines. Yellow fever vaccine is a live attenuated viral vaccine. Investigators have speculated that persons over 55 or 60 years of age may be at increased risk of this rare complication.

  • Marianneau P, Georges-Courbot M, Deubel V.  Rarity of adverse effects after 17D yellow-fever vaccination (commentary) Lancet 2001 Jul 14;358(9276):84-5. [link to pubmed abstract]

  • Vasconcelos PF, Luna EJ, Galler R, et al.  Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases. Lancet 2001 Jul 14;358(9276):91-7. [link to pubmed abstract]

  • Martin M, Tsai TF, Cropp B, et al. Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases.  Lance. 2001 Jul 14;358(9276):98-104. [link to pubmed abstract]

  • Chan RC, Penney DJ, Little D, et al.  Hepatitis and death following vaccination with 17D-204 yellow fever vaccineLancet 2001 Jul 14;358(9276):121-2. [link to pubmed abstract]

  • Yellow Fever Vaccine Requirements and Information on Malaria Risk and Prophylaxis, by Country  (from CDC) link

 

This page was last updated on February 12, 2014

2014 Institute for Vaccine Safety